Alembic Pharmaceuticals receives USFDA final approval for Sacubitril and Valsartan Tablets
Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death
Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death
Additional data from APPRAISE ATP trial reinforce modular therapy approach
The funds raised from the Whitathon run are utilized to treat underprivileged children suffering from Retinoblastoma
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
New leadership team announced at NATHEALTH Annual General Meeting 2024
WINREVAIR is a breakthrough biologic for this rare, progressive disease
Subscribe To Our Newsletter & Stay Updated